Jarrow Launches Phospholipid-Bound Omega-3 Supplement

February 17, 2012

Jarrow says that compared to triglyceride-bound omega-3s, phospholipid omega-3s offer higher bioavailability.

Jarrow Formulas (Los Angeles) is taking its stake in the fish oil omega-3 market with PhosphOmega, a dietary supplement aimed at improving omega-3 bioavailability over orginary fish oils.

PhosphOmega gets its name from the product’s emphasis on a phospholipid delivery form. Jarrow says that compared to triglyceride-bound omega-3s, phospholipid omega-3s offer higher bioavailability.

“The omega-3s in seafood are consumed both as phospholipids and triglycerides,” says marketing director Rory Lipsky. “Eighty percent of the fat in trout is phospholipid and twenty percent is tiglyceride. PhosphOmega provides omega-3s in both the triglyceride and phospholipid forms, just as nature intended.”

Jarrow’s new fish oil also contains 100 mcg of astaxanthin “to support a healthy immune response.” Heavy metal and PCB testing ensure low levels in each product.

Related Content:

Omega-3